GATA2 Recombinant Rabbit Monoclonal Antibody [PSH04-53] (HA722152)

UNIPROT #

P23769

PROTEIN NAME

GATA2

SYNONYMS

DCML antibody;Endothelial transcription factor GATA 2 antibody;Endothelial transcription factor GATA-2 antibody;Endothelial transcription factor GATA2 antibody;FLJ45948 antibody;GATA 2 antibody;GATA binding protein 2 antibody;GATA-binding protein 2 antibody;Gata2 antibody;GATA2_HUMAN antibody;IMD21 antibody;MGC2306 antibody;MONOMAC antibody;NFE 1B antibody;NFE1B antibody;OTTHUMP00000216240 antibody

SUBCELLULAR LOCATION

Nucleus.

FUNCTION

GATA2 or GATA-binding factor 2 is a transcription factor, i.e. a nuclear protein which regulates the expression of genes. It regulates many genes that are critical for the embryonic development, self-renewal, maintenance, and functionality of blood-forming, lympathic system-forming, and other tissue-forming stem cells. GATA2 is encoded by the GATA2 gene, a gene which often suffers germline and somatic mutations which lead to a wide range of familial and sporadic diseases, respectively. The gene and its product are targets for the treatment of these diseases. Inactivating mutations of the GATA2 gene cause a reduction in the cellular levels of GATA2 and the development of a wide range of familial hematological, immunological, lymphatic, and/or other disorders that are grouped together into a common disease termed GATA2 deficiency. Less commonly, these disorders are associated with non-familial (i.e. sporadic or acquired) GATA inactivating mutations. GATA2 deficiency often begins with seemingly benign abnormalities but if untreated progresses to life-threatening opportunistic infections, virus-induced cancers, lung failure, the myelodysplastic syndrome (i.e. MDS), and/or acute myeloid leukemia, principally acute myeloid leukemia (AML), less commonly chronic myelomonocytic leukemia (CMML), and rarely a lymphoid leukemia.